Amitriptyline updated on 07-01-2025

All congenital malformations (majors, minors, majors and minors, or unspecified)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S18162
R76886
Chan (Controls exposed to SSRIs), 2024 Any major malformations 1st trimester retrospective cohort (claims database) exposed to other treatment, sick excluded Adjustment: No Monotherapy: substance alone among all Antidep (SSRI, SNRI, ...) 1.12 [0.59;2.11] C
excluded (control group)
12/148   70/956 82 148
ref
S18150
R76887
Chan (Controls unexposed, general pop), 2024 Any major malformations 1st trimester retrospective cohort (claims database) unexposed (general population or NOS) Adjustment: Yes Monotherapy: substance alone among all Antidep (SSRI, SNRI, ...) 1.53 [0.84;2.77] 12/148   22,628/462,377 22,640 148
ref
S11188
R42241
Anderson, 2020 Major birth defects 1st trimester case control unexposed (general population or NOS) Adjustment: No Monotherapy: TCA only 0.91 [0.38;2.19] C 17/24   30,613/42,084 30,630 24
ref
S11597
R42499
Ozturk, 2016 Major congenital defects at least 1st trimester prospective cohort unexposed (general population or NOS) Adjustment: No Monotherapy: no or not specified 9.90 [0.43;229.94] C 0/4   3/246 3 4
ref
Total 3 studies 1.36 [0.74;2.49] 53,273 176
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Chan (Controls unexposed, general pop), 2024Chan, 2024 1 1.53[0.84; 2.77]22,64014861%ROB confusion: seriousROB selection: moderateROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Anderson, 2020Anderson, 2020 0.91[0.38; 2.19]30,6302436%ROB confusion: criticalROB selection: criticalROB classification: criticalROB missing: lowROB mesure: criticalROB reporting: moderate Ozturk, 2016Ozturk, 2016 9.90[0.43; 229.94]344%ROB confusion: criticalROB selection: unclearROB classification: moderateROB missing: lowROB mesure: moderateROB reporting: moderate Total (3 studies) I2 = 19% 1.36[0.74; 2.49]53,2731760.220.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls unexposed, general pop;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 2.00[0.55; 7.23]22,64315223%NAChan (Controls unexposed, general pop), 2024 Ozturk, 2016 2 case control studiescase control studies 0.91[0.38; 2.19]30,63024 -NAAnderson, 2020 1 Type of controls unexposed (disease free or unspecified)unexposed (disease free or unspecified) 1.36[0.74; 2.49]53,27317619%NAChan (Controls unexposed, general pop), 2024 Anderson, 2020 Ozturk, 2016 3 Tags Adjustment   - No  - No 1.83[0.22; 15.30]30,6332851%NAAnderson, 2020 Ozturk, 2016 2   - Yes  - Yes 1.53[0.84; 2.78]22,640148 -NAChan (Controls unexposed, general pop), 2024 1 Monotherapy   - no or not specified  - no or not specified 9.90[0.43; 229.94]34 -NAOzturk, 2016 1   - substance alone among all Antidep ( ...  - substance alone among all Antidep (SSRI, SNRI, ...) 1.53[0.84; 2.78]22,640148 -NAChan (Controls unexposed, general pop), 2024 1   - TCA only  - TCA only 0.91[0.38; 2.19]30,63024 -NAAnderson, 2020 1 All studiesAll studies 1.36[0.74; 2.49]53,27317619%NAChan (Controls unexposed, general pop), 2024 Anderson, 2020 Ozturk, 2016 30.220.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 18162

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.36[0.74; 2.49]53,27317619%NAChan (Controls unexposed, general pop), 2024 Anderson, 2020 Ozturk, 2016 3 exposed to other treatment, sick controlsexposed to other treatment, sick controls 1.12[0.59; 2.11]82148 -NAChan (Controls exposed to SSRIs), 2024 10.510.01.0